Aclaris Therapeutics, Inc.
ACRS
$1.36
-$0.135-9.06%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 113.59M | 127.72M | 111.09M | 128.17M | 119.11M |
| Total Receivables | 8.92M | 343.00K | 325.00K | 373.00K | 298.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.44M | 4.27M | 6.22M | 6.80M | 9.45M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 125.95M | 132.33M | 117.64M | 135.34M | 128.86M |
|
|
|||||
| Total Current Assets | 125.95M | 132.33M | 117.64M | 135.34M | 128.86M |
| Net Property, Plant & Equipment | 3.85M | 4.11M | 4.40M | 5.25M | 5.48M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 224.00K | 243.00K | 262.00K | 281.00K | 299.00K |
| Total Assets | 220.33M | 182.39M | 161.07M | 174.07M | 197.41M |
|
|
|||||
| Total Accounts Payable | 4.69M | 7.66M | 7.27M | 10.81M | 8.88M |
| Total Accrued Expenses | 7.60M | 3.14M | 3.40M | 3.18M | 10.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 481.00K | -- | 449.00K | 503.00K | 426.00K |
| Total Finance Division Other Current Liabilities | 18.83M | 8.02M | 4.56M | 5.58M | 10.79M |
| Total Other Current Liabilities | 18.83M | 8.02M | 4.56M | 5.58M | 10.79M |
| Total Current Liabilities | 31.60M | 18.82M | 15.68M | 20.08M | 30.95M |
|
|
|||||
| Total Current Liabilities | 31.60M | 18.82M | 15.68M | 20.08M | 30.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.12M | 2.25M | 2.37M | 2.97M | 3.07M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.06M | 31.18M | 9.20M | 9.00M | 6.20M |
| Total Liabilities | 64.77M | 52.24M | 27.25M | 32.05M | 40.23M |
|
|
|||||
| Common Stock & APIC | 1.06B | 936.03M | 933.01M | 930.12M | 928.08M |
| Retained Earnings | -902.86M | -806.31M | -798.72M | -787.74M | -770.80M |
| Treasury Stock & Other | 97.00K | 427.00K | -463.00K | -364.00K | -106.00K |
| Total Common Equity | 155.55M | 130.15M | 133.82M | 142.01M | 157.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 155.55M | 130.15M | 133.82M | 142.01M | 157.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 155.55M | 130.15M | 133.82M | 142.01M | 157.18M |
|
|
|||||
